Pathology's top genomic panel code averaged $2,855.75 per Medicare service in 2023. Cardiac surgery, the highest-paid specialty that actually touches patients, averaged $334.70. That gap is not a rounding error.

The physician who never enters the exam room earns more per Medicare claim than the surgeon who just repaired someone's heart. Understanding why requires looking past specialty labels and into the procedure codes underneath them.

When Procedure Mix Outweighs Specialty Designation

Medicare payment rates are set by procedure, not by the person performing it. That structural fact produces outcomes that look strange from the outside. Cardiac surgery leads all patient-facing physician specialties at $334.70 per service in 2023, ahead of neurosurgery at $243.42 and radiation oncology at $155.53. Cardiology, the specialty most people associate with high-stakes medicine, averaged just $58.79 per standardized service in 2023, up from $54.76 in 2013.

Pathology sits in a different category entirely. Its highest-billed code in 2023, HCPCS 81455 (a targeted genomic sequence analysis panel covering 51 or more genes), averaged $2,855.75 per service. That is 8.5 times what cardiac surgery earns per service and nearly 49 times what cardiology earns on a standardized basis. For patients and payers, this means the laboratory interpretation of a complex cancer panel generates more Medicare revenue per claim than almost any clinical encounter in the system.

The volume on code 81455 was limited: 3,150 services in 2023. But the dollar figure is real, and it reflects how genomic medicine has been priced into the fee schedule as a distinct, high-complexity category.

The Distance Between Pathology's Floor and Ceiling

Not every pathology code pays like a genomic panel. The spread within the specialty is enormous. Code G0416, the standard prostate needle biopsy pathology examination, averaged $194.75 per service in 2023 across 100,109 services. Code 88120, a manual cell examination of urine, averaged $351.24 per service in 2023, up from $313.22 in 2013 across a slightly larger volume of 47,747 services then versus 36,930 now.

The prostate biopsy code runs at 100,109 services and pays $194.75. The genomic panel runs at 3,150 services and pays $2,855.75. Pathology's average per-service payment across all codes sits somewhere between those poles, but the genomic codes pull the average up in ways that routine histology never could. For hospital systems and independent labs investing in genomic testing infrastructure, this pricing structure creates a direct financial incentive to expand panel-based testing.

What the Standardized Numbers Reveal About Clinical Specialties

Stripping out geographic variation makes the cardiology picture more striking. Cardiology's standardized payment per service grew from $54.76 in 2013 to $58.79 in 2023, a 7.4% increase over a decade. Neurosurgery's standardized rate was $139.96 in 2013 and $147.54 in 2022, a 5.4% increase. Both specialties saw modest, steady growth. Neither came close to matching what a single high-complexity pathology code generates per claim.

Radiation oncology, which averaged $155.53 per service in 2023 across more than 12 million services and 4,828 providers, sits in the middle of the patient-facing range. It sees patients, manages treatment courses over weeks, and still earns less per service than pathology's routine urine cytology code.

The fee schedule's logic is not irrational on its face: complex laboratory analysis of genomic material is expensive to perform and requires specialized expertise. But the comparison forces a question that Medicare's payment architects have not fully answered. Pathology code 81455 averaged $2,855.75 per service in 2023 across only 3,150 services. As genomic testing volumes grow and per-unit costs fall with scale, how much of pathology's per-service payment advantage survives, and who pays the difference while it does?